Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Connect Biopharma Holdings (CNTB)
NASDAQ:CNTB
RESEARCH TOOLSreports
Connect Biopharma Holdings (CNTB) Stock Price & Analysis
35 Followers
CNTB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.53 - $2.84
Previous Close$0.92
Volume81.46K
Average Volume (3M)189.51K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)¥550.27M
Total Debt (Recent Filing)¥3.00M
Price to Earnings (P/E)-0.6
Beta0.92
Next Earnings
Mar 28, 2024EPS Estimate
-$0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.58
Shares Outstanding55,041,247
10 Day Avg. Volume242,704
30 Day Avg. Volume189,514
Standard Deviation0.31
R-Squared0.02
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.05
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$7.00Price Target Upside660.87% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Connect Biopharma Holdings News
Ownership Overview
0.00%
Insiders
0.06% Mutual Funds
15.94% Other Institutional Investors
84.00% Public Companies and
Individual Investors
CNTB FAQ
What was Connect Biopharma Holdings’s price range in the past 12 months?
Connect Biopharma Holdings lowest stock price was $0.53 and its highest was $2.84 in the past 12 months.
What is Connect Biopharma Holdings’s market cap?
Currently, no data Available
When is Connect Biopharma Holdings’s upcoming earnings report date?
Connect Biopharma Holdings’s upcoming earnings report date is Mar 28, 2024 which is in 109 days.
How were Connect Biopharma Holdings’s earnings last quarter?
Connect Biopharma Holdings released its earnings results on Sep 12, 2023. The company reported -$0.548 earnings per share for the quarter, beating the consensus estimate of -$0.915 by $0.367.
Is Connect Biopharma Holdings overvalued?
According to Wall Street analysts Connect Biopharma Holdings’s price is currently Undervalued.
Does Connect Biopharma Holdings pay dividends?
Connect Biopharma Holdings does not currently pay dividends.
What is Connect Biopharma Holdings’s EPS estimate?
Connect Biopharma Holdings’s EPS estimate is -$0.29.
How many shares outstanding does Connect Biopharma Holdings have?
Connect Biopharma Holdings has 55,071,560 shares outstanding.
What happened to Connect Biopharma Holdings’s price movement after its last earnings report?
Connect Biopharma Holdings reported an EPS of -$0.548 in its last earnings report, beating expectations of -$0.915. Following the earnings report the stock price went up 2.632%.
Which hedge fund is a major shareholder of Connect Biopharma Holdings?
Among the largest hedge funds holding Connect Biopharma Holdings’s share is RA Capital Management. It holds Connect Biopharma Holdings’s shares valued at 6M.
---
Connect Biopharma Holdings Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
27.42%
12-Months-Change
Fundamentals
Return on Equity
-51.10%
Trailing 12-Months
Asset Growth
-39.09%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Connect Biopharma Holdings
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307, CBP-174, and CBP-233.
---
Top 5 ETFs holding CNTB
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold CNTB. The ETFs are listed according to market value of CNTB within the ETF
---